SELLAS Life Sciences (SLS) Current Taxes (2017)

SELLAS Life Sciences' (SLS) quarterly Current Taxes came in at $426000.0 in Q4 2017.

SELLAS Life Sciences (SLS) Current Taxes (2017) Analysis & Trends

SELLAS Life Sciences (SLS) has 1 years of Current Taxes data on file, last reported at $426000.0 in Q4 2017.

  • On a quarterly basis, Current Taxes changed N/A year-over-year to $426000.0 in Q4 2017; TTM through Dec 2017 was $426000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $426000.0, changed N/A from the prior year.
  • Current Taxes for Q4 2017 stood at $426000.0.
  • Over the last five years, Current Taxes for SLS reached as high as $426000.0 in Q4 2017 and fell as low as $426000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 SELLAS Life Sciences 3.23 Mn 3.23 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 426,000.00